World leaders gather to consolidate their commitment to ending TB. Vital to the success of renewed efforts is an overdue recognition of the pervasive and pernicious influence of TB stigma. TB stigma is sustained in structures, policies, traditions, and norms. Innovative modifications to infection control, drug dispensing, and surveillance practices are required to increase demand for TB screening and effective therapeutic alliances among those diagnosed. The authors argue that reducing TB stigma requires a scientific and inclusive process, with prominent roles for TB survivors and a willingness to integrate and learn from other stigmatized conditions.

Additional Metadata
Persistent URL,
Journal American Journal of Tropical Medicine and Hygiene
A. Daftary (Amrita), Mitchell, E.M.H, M.J.A. Reid (Michael), E. Fedaku (Endalkachew), & E. Goosby (Eric). (2018). To End TB, First-Ever High-Level Meeting on TB Must Address Stigma. American Journal of Tropical Medicine and Hygiene, 1–3. doi:10.4269/ajtmh.18-0591